PREVALENCE AND INCIDENCE ESTIMATIONS IN GERMAN AMNOG APPLICATIONS - THE ROLE OF REAL-WORLD EVIDENCE (RWE)

被引：0
|
作者：
Altevers, J. [1 ]
Borchert, K. [1 ]
Mittendorf, T. [1 ]
Braun, S. [1 ]
机构：
[1] Xcenda GmbH, Hannover, Germany
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1807
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP252
引用
收藏
页码：A558 / A558
页数：1
相关论文
共 50 条
  • [21] Real-world prevalence and incidence of lower back pain in Germany
    Karel Kostev
    [J]. Rheumatology International, 2019, 39 : 1113 - 1113
  • [22] Real-world prevalence and incidence of lower back pain in Germany
    Kostev, Karel
    [J]. RHEUMATOLOGY INTERNATIONAL, 2019, 39 (06) : 1113 - 1113
  • [23] Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
    Maison, Patrick
    Zureik, Mahmoud
    Hivert, Virginie
    Kjaer, Jesper
    Khonsari, Roman Hossein
    Trifiro, Gianluca
    Ratignier-Carbonneil, Christelle
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [24] Utilizing Real-World Evidence (RWE) to Improve Care in Chronic Lymphocytic Leukemia: Challenges and Opportunities
    Prioty Islam
    Anthony R. Mato
    [J]. Current Hematologic Malignancy Reports, 2020, 15 : 254 - 260
  • [25] RELEVANCE OF REAL WORLD DATA IN GERMAN AMNOG SUBMISSIONS IN ONCOLOGY
    Haas, J. S.
    Borchert, K.
    Loepmeier, J.
    Braun, S.
    Mittendorf, T.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A469 - A469
  • [26] Utilizing Real-World Evidence (RWE) to Improve Care in Chronic Lymphocytic Leukemia: Challenges and Opportunities
    Islam, Prioty
    Mato, Anthony R.
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (04) : 254 - 260
  • [27] THE RISE OF REAL-WORLD EVIDENCE (RWE) IN EU MARKETING AUTHORIZATION DECISIONS - PAST, PRESENT, AND FUTURE
    Haas, J.
    Meise, D.
    Braun, S.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S242 - S243
  • [28] USE OF REAL-WORLD EVIDENCE (RWE) TO VALIDATE A TRIAL-BASED HEALTH ECONOMIC MODEL
    Munakata, J.
    Li, H.
    Luo, R.
    Guo, Y.
    O'Sullivan, A.
    Duran, A.
    Nelson, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A325 - A325
  • [29] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    [J]. TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [30] REGULATORY VS HTA DIVERGENCES- CAN THE REAL-WORLD EVIDENCE (RWE) BE THE CONNECTING BRIDGE?
    Takyar, J.
    Gil, E.
    Gordon, M.
    Bergemann, R.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S384 - S384
12345